MDC1 and cancer: Additionally, USP15, recruited to DSBs by MDC1, deubiquitinates BARD1 [138, 139], a BRCA1 binding partner, facilitating the interaction between BARD1 and HP1γ at DSBs, thus enhancing olaparib resistance in cancer cells [140].